http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0725644-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32442a1761c50204a02025c8ed897f52 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
filingDate | 1994-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f7f3c3ab0dddadffc42e374209d9367 |
publicationDate | 1996-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0725644-A1 |
titleOfInvention | Budesonide medicament to improve enteral fluid resorption, especially following post-operative conditions |
abstract | The invention relates to the use of budesonide to treat conditions arising from reduced enteral fluid resorption, especially post-operative conditions. These conditions are, for example, diarrhoeas following every kind of intestinal resection, in atrophy of the intestinal mucous membrane, in amyloiditis and Whipple's disease, in adrenal insufficiency, in indigenous and tropical sprue, in HIV infection or following exsudative enteropathy. |
priorityDate | 1993-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.